Yüklüyor......

Rational, biologically based treatment of EGFR-mutant non-small-cell lung cancer

Epidermal growth factor receptor (EGFR)-mutant non-small-cell lung cancer (NSCLC) was first recognized in 2004 as a distinct, clinically relevant molecular subset of lung cancer. The disease has been the subject of intensive research at both the basic scientific and clinical levels, becoming a parad...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Pao, William, Chmielecki, Juliann
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2010
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3072803/
https://ncbi.nlm.nih.gov/pubmed/20966921
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/nrc2947
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!